Member Info for LiveLongnProsper

And just to reiterate ...
"POINT's CanSEEK™ has been sub-licensed from both Bach Biosciences and Avacta Life Sciences, which has branded the technology as pre | CISION™ (an Avacta trademark)."
POINT are 'locked in' to Avacta, simply demonstrates our massive valuation deficit. Roll on AVA6000 PK read out.
GLA

@Energy, don't disagree. So long as success with AVA6000 (soon) and we retain IPR for Affimers and TMAC.
GLA

@Energy, yes been thinking the same for a while. Massive Synergy. But we also have Affimers (not just for LFT's) and, potentially, TMAC which combines the 2 tech platforms.
GLA

https://www.medrxiv.org/content/10.1101/2021.12.24.21268174v1
Yep, I know there are many more (see below), but this one seems to have got some attention?
https://nextstrain.org/ncov/gisaid/global
Clearly an ongoing need for super high quality and quickly adaptable tests.
GLA

This Twit post seems to express some concerns, no idea why …?
https://twitter.com/SunderlandLolly/status/1476809356230418441
GLA

#abakta coverage from Korea (South, I expect) …
https://www.theguru.co.kr/news/tag_list_all.html?tag=%EC%95%84%EB%B0%95%ED%83%80&page=0
and in China (at the bottom) ,,,
http://www.stylechina.com/News/Info_11263_105_0_0.html
Oh yes, and Medusa19 were ‘liked’ by Lorraine in Oslo, so no doubt we are on the verge of something great …
https://no.linkedin.com/in/lorraine-wedlog-656124a1
GLA

From the Cambridge Independent today …
https://www.cambridgeindependent.co.uk/business/avacta-s-covid-19-test-earns-ce-mark-for-consumer-use-9232628/
And they do highlight that (unbelievably) …
“It is still awaiting a government desktop review, however, before it can go on sale in the UK.”
Needs to hit the national press.
GLA

I particularly like the footnote on the 'pipeline' page ...
"POINT's CanSEEK™ has been sub-licensed from both Bach Biosciences and Avacta Life Sciences, which has branded the technology as pre | CISION™ (an Avacta trademark)."
Safe 'Nuking' of cancer with POINT or via 'Chemo' from Avacta.
Great year ahead.
GLA

https://covid-19-diagnostics.jrc.ec.europa.eu/devices/detail/2426
Updated 14/12/21, but needs more updates - Omnicron, validation results, etc.
Shows why we need the Regulatory Affairs post filling.
GLA

£291.5k above UT
GLA

Being discussed on Twit just now, so thanks to dom @dom13033596.
“International Relations and Defence Committee The UK and China’s security and trade relationship: A strategic void”. House of Lords paper dating from 10 Sept 2021. Section 7 331 and 335 perhaps of interest …?
https://publications.parliament.uk/pa/ld5802/ldselect/ldintrel/62/6210.htm#_idTextAnchor118
Wonder if ‘their Lordships’ are more interested in UK Diagnostics than our elected ‘representatives’?
GLA

Yep, small 'flock' of them let out on Twit this morning, might as well call them all Dolly.
GLA

This time Investor info ...
https://avacta.com/investors/key-information/
Not sure what's changed.
GLA

https://twitter.com/Mstambo999/status/1470772635705483278
Courtesy @Mstambo999 from Twit.
GLA

@gmcc, yes a bit odd, the careers pages updated today, but even if you logon you get ...
"Video unavailable
This video is private."
Also notable that they are still trying to hire a 'Regulatory Affairs Manager' - which is clearly a badly needed role, as we all know!
GLA

Meduflow discussed earlier here, this courtesy of Lloyd@EmmersonPotash from Twit …
https://euipo.europa.eu/eSearch/#basic/1+1+1+1/meduflow
Updated on 08/12/2021, but registration date still blank.
Medusa19 representatives - Wilson Gunn (Europe), Gudridarstig 2-4, Reykjavik 113, ISLANDIA
Progress, but needs to move more quickly (please).
GLA

Just to add re AVA6000 ...
"US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for AVA6000. This will allow the Group to expand its Phase I clinical trial, ALS-6000-101, into clinical trial sites in the United States."
We will be more visible than ever in the USA shortly.
GLA

Sujood 'ramp'?
Surely the Guru of gurus, Sage of sages, just says 'truth' (cough...., haha)?
GLA

Medusa19 RSPT …
https://www.medusa19.com/en/rapid-saliva-protein-test/
“Developed in the UK and Spain, the test is CE marked to 98/79/EC, registered with the MHRA, and is for use under supervision from a medical professional throughout Europe.”
GLA

Would appreciate early notice of icebergs.
GLA